Hepion Pharmaceuticals, Inc. (HEPA)
0.066
-0.01
(-7.11%)
USD |
OTCM |
Sep 03, 16:00
Hepion Pharmaceuticals Shareholders Equity (Quarterly) : 1.278M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.278M |
| March 31, 2026 | 1.857M |
| December 31, 2025 | 2.668M |
| September 30, 2025 | 3.324M |
| June 30, 2025 | 3.797M |
| March 31, 2025 | 3.896M |
| December 31, 2024 | -1.863M |
| September 30, 2024 | -0.4067M |
| June 30, 2024 | 3.562M |
| March 31, 2024 | 7.521M |
| December 31, 2023 | 7.281M |
| September 30, 2023 | 16.16M |
| June 30, 2023 | 26.37M |
| March 31, 2023 | 37.15M |
| December 31, 2022 | 49.86M |
| September 30, 2022 | 59.26M |
| June 30, 2022 | 67.32M |
| March 31, 2022 | 86.64M |
| December 31, 2021 | 93.00M |
| September 30, 2021 | 102.64M |
| June 30, 2021 | 110.72M |
| March 31, 2021 | 117.57M |
| December 31, 2020 | 40.52M |
| September 30, 2020 | 12.87M |
| June 30, 2020 | 18.29M |
| Date | Value |
|---|---|
| March 31, 2020 | 18.77M |
| December 31, 2019 | 16.19M |
| September 30, 2019 | 16.23M |
| June 30, 2019 | 18.03M |
| March 31, 2019 | 0.6455M |
| December 31, 2018 | 1.975M |
| September 30, 2018 | 4.654M |
| June 30, 2018 | -0.7515M |
| March 31, 2018 | 3.052M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 1.318M |
| March 31, 2016 | 1.295M |
| December 31, 2015 | 4.984M |
| September 30, 2015 | -1.361M |
| June 30, 2015 | 3.439M |
| March 31, 2015 | 7.884M |
| December 31, 2014 | 8.604M |
| September 30, 2014 | 0.5399M |
| June 30, 2014 | -2.933M |
| March 31, 2014 | -7.342M |
| December 31, 2013 | -0.4899M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.927M |
| Total Liabilities (Quarterly) | 0.6489M |
| Current Ratio | 3.911 |
| Net Debt Paydown Yield | 5.33% |